. Step 33 of 41
Clinical Stem 3
A patient with right upper lobe adenocarcinoma progressing on biomarker-directed therapy

Question 9
At this point, what would you do?
A. Defer molecular testing to the treating oncologist

B. Defer molecular testing to the pathologist

C. Order the tests based on the previous discussions with the oncologist and the pathologist

D. Do not order any tests until after lung cancer tissue acquisition, handling and processing are streamlined at your institution
incorrect correct
Each fictitious clinical case scenario is based on a conglomerate of real patient data. Cases have been modified to avoid any possibility for patient identification and to help meet educational objectives. Any resemblance to real persons, living or deceased, is purely coincidental.

The content for these webcasts has been developed by members of the World Association for Bronchology and Interventional Pulmonology. All content was reviewed by an independent multidisciplinary team of experts. Unless otherwise specified, all content is the property of WABIP.
A collaborative project with Pfizer Oncology